Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial

BACKGROUND: Viral load (VL) testing is key in monitoring adherence to antiretroviral therapy (ART) and documenting HIV treatment response. As per HIV treatment guidelines in Uganda, the first VL test is recommended 6 months after initiation of ART. Undetectable VL (uVL) at ART initiation may be help...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabagaya, Grace, Rukundo, Gordon, Amone, Alexander, Wavamunno, Priscilla, Namale-Matovu, Joyce, Lubega, Irene, Nakabiito, Clemensia, Namukwaya, Zikulah, Nolan, Monica, Malamba, Samuel S., King, Rachel, Homsy, Jaco, Fowler, Mary Glenn, Musoke, Philippa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417996/
https://www.ncbi.nlm.nih.gov/pubmed/34481464
http://dx.doi.org/10.1186/s12879-021-06608-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417996/
https://www.ncbi.nlm.nih.gov/pubmed/34481464
http://dx.doi.org/10.1186/s12879-021-06608-4

Ejemplares similares